Company / Share Buybacks
Esperion Therapeutics, Inc. Share Buybacks History
FY2018-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Share Buybacks
-
FY2021
5-year range
$0 / $0
FY2018-FY2021
Trend
-100.0%
vs FY2020
Sector context
#42 of 48
Health Care
What the data says
Remained stable around $0 over the past 2 years.
Health Care sector context is included.
Share Buybacks over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 48
▼
Key checks
Key Insights
- In FY2021, share buybacks decreased 100.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.60 (distress zone, below 1.8 threshold)
- Negative profit margin: -15.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Share BuybacksValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $0 | -100.0% |
| FY2020 | $55.0M | - |
| FY2019 | $0 | - |
| FY2018 | $0 | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2021 · SEC 10-K · Updated Jul 2, 2026